DE4140185C2
(de)
*
|
1991-12-05 |
1996-02-01 |
Alfatec Pharma Gmbh |
Ein 2-Arylpropionsäurederivat in Nanosolform enthaltendes Arzneimittel und seine Herstellung
|
IT1255895B
(it)
*
|
1992-10-20 |
1995-11-17 |
Laura Chiodini |
Composizioni farmaceutiche contenenti una calcitonina
|
US6022852A
(en)
*
|
1993-10-22 |
2000-02-08 |
Hexal Ag |
Pharmaceutical composition containing cyclosporin A
|
US5952004A
(en)
*
|
1994-03-18 |
1999-09-14 |
Shire Laboratories Inc. |
Emulsified drug delivery systems
|
GB9409778D0
(en)
*
|
1994-05-16 |
1994-07-06 |
Dumex Ltd As |
Compositions
|
US7205279B2
(en)
*
|
1995-10-25 |
2007-04-17 |
Novartis Ag |
Pharmaceutical compositions
|
US5571536A
(en)
*
|
1995-02-06 |
1996-11-05 |
Nano Systems L.L.C. |
Formulations of compounds as nanoparticulate dispersions in digestible oils or fatty acids
|
JP3471977B2
(ja)
*
|
1995-06-02 |
2003-12-02 |
信越化学工業株式会社 |
液体状可塑剤を用いる無溶媒腸溶性コーティング剤で被覆した腸溶性製剤
|
DE19521974A1
(de)
*
|
1995-06-16 |
1996-12-19 |
Hexal Pharmaforschung Gmbh |
Pharmazeutische Zubereitung mit Cyclosporin A
|
WO1997002815A1
(fr)
*
|
1995-07-07 |
1997-01-30 |
Nippon Kayaku Kabushiki Kaisha |
Composition de flutamide
|
US6730679B1
(en)
|
1996-03-22 |
2004-05-04 |
Smithkline Beecham Corporation |
Pharmaceutical formulations
|
US5726154A
(en)
*
|
1996-06-28 |
1998-03-10 |
University Of Utah Research Foundation |
Stabilization and oral delivery of calcitonin
|
US8022095B2
(en)
*
|
1996-08-16 |
2011-09-20 |
Pozen, Inc. |
Methods of treating headaches using 5-HT agonists in combination with long-acting NSAIDs
|
JP2001523221A
(ja)
*
|
1996-09-01 |
2001-11-20 |
ファーモス コーポレイション |
親油性物質の促進された生物学的利用能のための固形共沈物
|
US5891469A
(en)
*
|
1997-04-02 |
1999-04-06 |
Pharmos Corporation |
Solid Coprecipitates for enhanced bioavailability of lipophilic substances
|
US5922352A
(en)
*
|
1997-01-31 |
1999-07-13 |
Andrx Pharmaceuticals, Inc. |
Once daily calcium channel blocker tablet having a delayed release core
|
US5837379A
(en)
*
|
1997-01-31 |
1998-11-17 |
Andrx Pharmaceuticals, Inc. |
Once daily pharmaceutical tablet having a unitary core
|
AU9496798A
(en)
*
|
1997-09-19 |
1999-04-05 |
Shire Laboratories, Inc. |
Solid solution beadlet
|
FR2771292B1
(fr)
*
|
1997-11-21 |
2000-02-18 |
Ethypharm Lab Prod Ethiques |
Spheroides contenant de la tiagabine, procede de preparation et compositions pharmaceutiques
|
US5891845A
(en)
*
|
1997-11-21 |
1999-04-06 |
Fuisz Technologies Ltd. |
Drug delivery systems utilizing liquid crystal structures
|
JP3664652B2
(ja)
*
|
1997-12-03 |
2005-06-29 |
日本水産株式会社 |
中種と被覆層からなるレンジ加熱冷凍食品用コーティング剤およびそれを用いた食品
|
US6485748B1
(en)
|
1997-12-12 |
2002-11-26 |
Andrx Pharmaceuticals, Inc. |
Once daily pharmaceutical tablet having a unitary core
|
US5891888A
(en)
*
|
1998-01-14 |
1999-04-06 |
Strahl; Robert Charles |
Physical endurance drink
|
BR9907195A
(pt)
*
|
1998-01-22 |
2000-10-10 |
Abbott Lab |
" formulações de tiagabina de liberação prolongada com efeitos colaterais reduzidos "
|
ZA99407B
(en)
*
|
1998-01-22 |
1999-07-20 |
Abbott Lab |
Extended release tiagabine formulations with reduced side-effects.
|
DE19819273A1
(de)
*
|
1998-04-30 |
1999-11-11 |
Pharmatec International S Giul |
Pharmazeutische Ciclosporin-Formulierung mit verbesserten biopharmazeutischen Eigenschaften, erhöhter physikalischer Qualität und Stabilität sowie Verfahren zur Herstellung
|
US5869704A
(en)
*
|
1998-08-24 |
1999-02-09 |
Eastman Chemical Company |
Water-dispersible or water-soluble D-tocotrienol compounds and methods for making therefor
|
CN1236813C
(zh)
|
1998-12-11 |
2006-01-18 |
药品处理公司 |
水难溶性药物的自乳化组合物
|
JP2002534370A
(ja)
|
1998-12-30 |
2002-10-15 |
デクセル リミテッド |
サイクロスポリンを送達するための分散可能な濃縮物
|
US7771746B2
(en)
*
|
1999-12-03 |
2010-08-10 |
Polichem Sa |
Methods for making sustained-release pharmaceutical compositions of ergot alkaloids having improved bioavailability and compositions thereof
|
US7732404B2
(en)
|
1999-12-30 |
2010-06-08 |
Dexcel Ltd |
Pro-nanodispersion for the delivery of cyclosporin
|
US20020102301A1
(en)
*
|
2000-01-13 |
2002-08-01 |
Joseph Schwarz |
Pharmaceutical solid self-emulsifying composition for sustained delivery of biologically active compounds and the process for preparation thereof
|
US6544555B2
(en)
|
2000-02-24 |
2003-04-08 |
Advancis Pharmaceutical Corp. |
Antibiotic product, use and formulation thereof
|
US6565882B2
(en)
|
2000-02-24 |
2003-05-20 |
Advancis Pharmaceutical Corp |
Antibiotic composition with inhibitor
|
US6384248B1
(en)
*
|
2000-08-17 |
2002-05-07 |
Fan Tech Ltd |
Meadowfoam based sorbitan esters
|
US20020068078A1
(en)
|
2000-10-13 |
2002-06-06 |
Rudnic Edward M. |
Antifungal product, use and formulation thereof
|
US6541014B2
(en)
|
2000-10-13 |
2003-04-01 |
Advancis Pharmaceutical Corp. |
Antiviral product, use and formulation thereof
|
ES2290095T3
(es)
*
|
2000-12-27 |
2008-02-16 |
Ares Trading S.A. |
Microparticulas lipidicas por micronizacion criogenica.
|
US20030157170A1
(en)
*
|
2001-03-13 |
2003-08-21 |
Richard Liggins |
Micellar drug delivery vehicles and precursors thereto and uses thereof
|
WO2002072150A2
(en)
*
|
2001-03-13 |
2002-09-19 |
Angiotech Pharmaceuticals Inc. |
Micellar drug delivery vehicles and uses thereof
|
DE60220519T2
(de)
*
|
2001-04-20 |
2007-09-27 |
The University Of British Columbia, Vancouver |
Mizellares arzneistoffverabreichungssystem für hydrophobe arzneistoffe
|
AR033711A1
(es)
*
|
2001-05-09 |
2004-01-07 |
Novartis Ag |
Composiciones farmaceuticas
|
US20030113366A1
(en)
*
|
2001-12-14 |
2003-06-19 |
Macgregor Alexander |
Reverse-micellar delivery system for controlled transportation and enhanced absorption of agents
|
KR20030065831A
(ko)
*
|
2002-02-01 |
2003-08-09 |
주식회사 태평양 |
사이클로스포린을 함유한 지속 방출형 약학적 조성물
|
EP2087882A1
(de)
*
|
2002-03-26 |
2009-08-12 |
Teva Pharmaceutical Industries Ltd. |
Arzneimittelmikropartikel
|
US20040191207A1
(en)
*
|
2003-03-31 |
2004-09-30 |
Lipari John M. |
Alpha-hydroxy acid ester drug delivery compositions and methods of use
|
CA2533178C
(en)
|
2003-07-21 |
2014-03-11 |
Advancis Pharmaceutical Corporation |
Antibiotic product, use and formulation thereof
|
WO2005009364A2
(en)
|
2003-07-21 |
2005-02-03 |
Advancis Pharmaceutical Corporation |
Antibiotic product, use and formulation thereof
|
CA2533292C
(en)
|
2003-07-21 |
2013-12-31 |
Advancis Pharmaceutical Corporation |
Antibiotic product, use and formulation thereof
|
WO2005016311A1
(en)
|
2003-08-11 |
2005-02-24 |
Advancis Pharmaceutical Corporation |
Robust pellet
|
AU2004264356B2
(en)
|
2003-08-12 |
2011-01-27 |
Shionogi, Inc. |
Antibiotic product, use and formulation thereof
|
JP5686494B2
(ja)
|
2003-08-29 |
2015-03-18 |
シオノギ インコーポレイテッド |
抗生物質製剤、その使用法及び作成方法
|
EP1663169A4
(de)
|
2003-09-15 |
2010-11-24 |
Middlebrook Pharmaceuticals In |
Antibiotisches produkt, seine verwendung und formulierung
|
JP2007517908A
(ja)
*
|
2004-01-16 |
2007-07-05 |
グラクソ グループ リミテッド |
腸溶性ポリマー中における脂質基材の処方のカプセル封入
|
GB2411355B
(en)
|
2004-02-27 |
2006-02-22 |
Niche Generics Ltd |
Pharmaceutical composition
|
US20050260303A1
(en)
*
|
2004-03-08 |
2005-11-24 |
Tritch Daniel L |
Sports drink
|
US20050266082A1
(en)
*
|
2004-05-26 |
2005-12-01 |
Patel Satishkumar A |
Preparation of stable paroxetine HC1 ER tablets using a melt granulation process
|
JP2008505124A
(ja)
|
2004-07-02 |
2008-02-21 |
アドバンシス ファーマスーティカル コーポレイション |
パルス送達用錠剤
|
US20060008527A1
(en)
*
|
2004-07-09 |
2006-01-12 |
Yury Lagoviyer |
Controlled phase composition technology as an improved process for protection of drugs
|
EP1781257B1
(de)
*
|
2004-08-13 |
2018-12-19 |
Emisphere Technologies, Inc. |
Pharmazeutische formulierungen mit mikropartikeln oder nanopartikeln eines zufuhrmittels
|
KR20070118069A
(ko)
*
|
2004-12-09 |
2007-12-13 |
인시스 테라퓨틱스, 인코포레이티드 |
실온에서 안정한 드로나비놀 제형
|
GB2426703B
(en)
*
|
2005-05-31 |
2007-09-19 |
Malvern Cosmeceutics Ltd |
Compositions
|
TW200800305A
(en)
*
|
2005-07-26 |
2008-01-01 |
Glaxo Group Ltd |
Encapsulation of lipid-based formulations in enteric polymers
|
US9265724B2
(en)
|
2005-11-07 |
2016-02-23 |
Ram B. Murty |
Oral dosage form of tetrahydrocannabinol and a method of avoiding and/or suppressing hepatic first pass metabolism via targeted chylomicron/lipoprotein delivery
|
US8357394B2
(en)
|
2005-12-08 |
2013-01-22 |
Shionogi Inc. |
Compositions and methods for improved efficacy of penicillin-type antibiotics
|
US8778924B2
(en)
|
2006-12-04 |
2014-07-15 |
Shionogi Inc. |
Modified release amoxicillin products
|
US8299052B2
(en)
|
2006-05-05 |
2012-10-30 |
Shionogi Inc. |
Pharmaceutical compositions and methods for improved bacterial eradication
|
AU2007281918A1
(en)
*
|
2006-08-04 |
2008-02-14 |
Insys Therapeutics Inc. |
Aqueous dronabinol formulations
|
KR20080047957A
(ko)
*
|
2006-11-27 |
2008-05-30 |
주식회사 엠디바이오알파 |
고혈압의 치료 및 예방을 위한 약제 조성물
|
WO2009020666A1
(en)
*
|
2007-08-06 |
2009-02-12 |
Insys Therapeutics Inc. |
Oral cannabinoid liquid formulations and methods of treatment
|
MX2010010214A
(es)
*
|
2008-03-20 |
2010-12-21 |
Virun Inc |
Derivados de vitamina e y sus usos.
|
PL2268160T3
(pl)
|
2008-03-20 |
2013-05-31 |
Virun Inc |
Emulsje zawierające pochodną PEG tokoferolu
|
US8337931B2
(en)
*
|
2008-06-23 |
2012-12-25 |
Virun, Inc. |
Compositions containing non-polar compounds
|
PT2350075E
(pt)
|
2008-09-22 |
2014-06-09 |
Array Biopharma Inc |
Compostos imidazo[1,2b]piridazina substituídos como inibidores da trk cinase
|
SG10201914059WA
(en)
|
2008-10-22 |
2020-03-30 |
Array Biopharma Inc |
Substituted pyrazolo[1,5-a]pyrimidine compounds as trk kinase inhibitors
|
AR077468A1
(es)
|
2009-07-09 |
2011-08-31 |
Array Biopharma Inc |
Compuestos de pirazolo (1,5 -a) pirimidina sustituidos como inhibidores de trk- quinasa
|
US10210216B2
(en)
*
|
2009-12-18 |
2019-02-19 |
Sybase, Inc. |
Dynamic attributes for mobile business objects
|
CN103037708B
(zh)
|
2010-03-23 |
2015-05-20 |
维尔恩公司 |
含有蔗糖脂肪酸酯的纳米乳液
|
MX365251B
(es)
|
2010-05-20 |
2019-05-28 |
Array Biopharma Inc |
Compuestos macrocíclicos como inhibidores de trk cinasa.
|
WO2011162802A1
(en)
|
2010-06-21 |
2011-12-29 |
Virun, Inc. |
Compositions containing non-polar compounds
|
WO2012033478A1
(en)
*
|
2010-09-07 |
2012-03-15 |
Murty Pharmaceuticals, Inc. |
An improved oral dosage form of tetrahydrocannabinol and a method of avoiding and/or suppressing hepatic first pass metabolism via targeted chylomicron/lipoprotein delivery
|
US10874122B2
(en)
|
2012-02-10 |
2020-12-29 |
Virun, Inc. |
Beverage compositions containing non-polar compounds
|
US9351517B2
(en)
|
2013-03-15 |
2016-05-31 |
Virun, Inc. |
Formulations of water-soluble derivatives of vitamin E and compositions containing same
|
US9693574B2
(en)
|
2013-08-08 |
2017-07-04 |
Virun, Inc. |
Compositions containing water-soluble derivatives of vitamin E mixtures and modified food starch
|
US9861611B2
(en)
|
2014-09-18 |
2018-01-09 |
Virun, Inc. |
Formulations of water-soluble derivatives of vitamin E and soft gel compositions, concentrates and powders containing same
|
US10016363B2
(en)
|
2014-09-18 |
2018-07-10 |
Virun, Inc. |
Pre-spray emulsions and powders containing non-polar compounds
|
CN113354649A
(zh)
|
2014-11-16 |
2021-09-07 |
阵列生物制药公司 |
一种新的晶型
|
CA3003153A1
(en)
|
2015-10-26 |
2017-05-04 |
Loxo Oncology, Inc. |
Point mutations in trk inhibitor-resistant cancer and methods relating to the same
|
PE20181888A1
(es)
|
2016-04-04 |
2018-12-11 |
Loxo Oncology Inc |
Formulaciones liquidas de (s)-n-(5-((r)-2-(2,5-difluorofenil)-pirrolidin-1-il)-pirazolo[1,5-a]pirimidin-3-il)-3-hidroxipirrolidina-1-carboxamida
|
US10045991B2
(en)
|
2016-04-04 |
2018-08-14 |
Loxo Oncology, Inc. |
Methods of treating pediatric cancers
|
RU2745953C2
(ru)
|
2016-05-18 |
2021-04-05 |
Локсо Онколоджи, Инк. |
Способ получения (s)-n-(5-((r)-2-(2,5-дифторфенил)пирролидин-1-ил)-пиразоло[1,5-a]пиримидин-3-ил)-3-гидроксипирролидин-1-карбоксамида и его солей
|
JOP20190092A1
(ar)
|
2016-10-26 |
2019-04-25 |
Array Biopharma Inc |
عملية لتحضير مركبات بيرازولو[1، 5-a]بيريميدين وأملاح منها
|
WO2018136661A1
(en)
|
2017-01-18 |
2018-07-26 |
Andrews Steven W |
SUBSTITUTED PYRAZOLO[1,5-a]PYRAZINE COMPOUNDS AS RET KINASE INHIBITORS
|
JOP20190213A1
(ar)
|
2017-03-16 |
2019-09-16 |
Array Biopharma Inc |
مركبات حلقية ضخمة كمثبطات لكيناز ros1
|
WO2018174938A1
(en)
|
2017-03-23 |
2018-09-27 |
Virun, Inc. |
Stable dry powders and emulsions containing probiotics and mucoadhesive protein
|
TWI812649B
(zh)
|
2017-10-10 |
2023-08-21 |
美商絡速藥業公司 |
6-(2-羥基-2-甲基丙氧基)-4-(6-(6-((6-甲氧基吡啶-3-基)甲基)-3,6-二氮雜雙環[3.1.1]庚-3-基)吡啶-3-基)吡唑并[1,5-a]吡啶-3-甲腈之調配物
|
TW201932464A
(zh)
|
2018-01-18 |
2019-08-16 |
美商亞雷生物製藥股份有限公司 |
作為ret激酶抑制劑之經取代吡唑基[4,3-c]吡啶化合物
|
US11524963B2
(en)
|
2018-01-18 |
2022-12-13 |
Array Biopharma Inc. |
Substituted pyrazolo[3,4-d]pyrimidines as RET kinase inhibitors
|
TWI802635B
(zh)
|
2018-01-18 |
2023-05-21 |
美商亞雷生物製藥股份有限公司 |
作為ret激酶抑制劑之經取代吡咯并[2,3-d]嘧啶化合物
|
ES2922314T3
(es)
|
2018-09-10 |
2022-09-13 |
Array Biopharma Inc |
Compuestos heterocíclicos condensados como inhibidores de cinasa RET
|